Neurofront Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

Neurofront General Information

Description

Developer of an innovative neuroscience treatments intended to address China specific unmet medical needs with top notch development and commercial capabilities. The company aim to bridge the gap of innovative neuroscience treatments between China and global leaders by bringing their breakthrough therapies enabling patient to live better in China and Asia.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 2503, 25th Floor, Tower Two, Century Plaza
  • 1196 Century Avenue, Pudong New Area
  • Shanghai
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Room 2503, 25th Floor, Tower Two, Century Plaza
  • 1196 Century Avenue, Pudong New Area
  • Shanghai
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurofront Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 03-Sep-2020 Completed Startup
To view Neurofront’s complete valuation and funding history, request access »

Neurofront Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Pivotal BioVenture Partners (China) Venture Capital Minority
Pivotal Life Sciences Asset Manager Minority
To view Neurofront’s complete investors history, request access »

Neurofront FAQs

  • When was Neurofront founded?

    Neurofront was founded in 2020.

  • Where is Neurofront headquartered?

    Neurofront is headquartered in Shanghai, China.

  • What industry is Neurofront in?

    Neurofront’s primary industry is Drug Discovery.

  • Is Neurofront a private or public company?

    Neurofront is a Private company.

  • What is Neurofront’s current revenue?

    The current revenue for Neurofront is .

  • Who are Neurofront’s investors?

    Pivotal BioVenture Partners (China) and Pivotal Life Sciences have invested in Neurofront.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process